Show simple item record

dc.contributor.authorIkeda, Kohai
dc.contributor.authorMarutani, Eizo
dc.contributor.authorHirai, Shuichi
dc.contributor.authorWood, Mark E.
dc.contributor.authorWhiteman, Matthew
dc.contributor.authorIchinose, Fumito
dc.date.accessioned2015-11-11T10:34:19Z
dc.date.issued2015-09-15
dc.description.abstractAims Mitochondria-targeted hydrogen sulfide donor AP39, [(10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5yl)phenoxy)decyl) triphenylphosphonium bromide], exhibits cytoprotective effects against oxidative stress in vitro. We examined whether or not AP39 improves the neurological function and long term survival in mice subjected to cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). Methods Adult C57BL/6 male mice were subjected to 8 min of CA and subsequent CPR. We examined the effects of AP39 (10, 100, 1000 nmol kg−1) or vehicle administered intravenously at 2 min before CPR (Experiment 1). Systemic oxidative stress levels, mitochondrial permeability transition, and histological brain injury were assessed. We also examined the effects of AP39 (10, 1000 nmol kg−1) or vehicle administered intravenously at 1 min after return of spontaneous circulation (ROSC) (Experiment 2). ROSC was defined as the return of sinus rhythm with a mean arterial pressure >40 mm Hg lasting at least 10 seconds. Results Vehicle treated mice subjected to CA/CPR had poor neurological function and 10-day survival rate (Experiment 1; 15%, Experiment 2; 23%). Administration of AP39 (100 and 1000 nmol kg−1) 2 min before CPR significantly improved the neurological function and 10-day survival rate (54% and 62%, respectively) after CA/CPR. Administration of AP39 before CPR attenuated mitochondrial permeability transition pore opening, reactive oxygen species generation, and neuronal degeneration after CA/CPR. Administration of AP39 1 min after ROSC at 10 nmol kg−1, but not at 1000 nmol kg−1, significantly improved the neurological function and 10-day survival rate (69%) after CA/CPR. Conclusion The current results suggest that administration of mitochondria-targeted sulfide donor AP39 at the time of CPR or after ROSC improves the neurological function and long term survival rates after CA/CPR by maintaining mitochondrial integrity and reducing oxidative stress.en_GB
dc.description.sponsorshipNational Institutes of Healthen_GB
dc.identifier.citationVol. 49, pp. 90 - 96en_GB
dc.identifier.doi10.1016/j.niox.2015.05.001
dc.identifier.grantnumberHL101930en_GB
dc.identifier.otherS1089860315002104
dc.identifier.urihttp://hdl.handle.net/10871/18615
dc.language.isoenen_GB
dc.publisherAcademic Press Inc.en_GB
dc.rights.embargoreasonPublisher policyen_GB
dc.rightsAccepted manuscript: © 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/en_GB
dc.subjectCardiac arresten_GB
dc.subjectHydrogen sulfideen_GB
dc.subjectMitochondriaen_GB
dc.subjectResuscitationen_GB
dc.titleMitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in miceen_GB
dc.typeArticleen_GB
dc.identifier.issn1089-8603
dc.identifier.issn1089-8603
dc.descriptionCopyright © 2015 Elsevier. NOTICE: this is the author’s version of a work that was accepted for publication in <Journal title>. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Nitric Oxide, Vol. 49, pp. 90–96 (2015), DOI:10.1016/j.niox.2015.05.001en_GB
dc.identifier.journalNitric Oxideen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record